Assay+ Covid 19 Igg/igm Rapid Test

Bioassayplus Inc.

Product Description

  • Brand Name: Assay+
  • The Assay+ Covid-19 IgM/IgG rapid test is a lateral flow chromatographic immunoassay to qualitatively to detect and differentiate IgM   and IgG antibodies to Covid-19 in serum, plasma or whole blood specimens from the patients suspected with Covid-19 infection.
     
    Test results from Assay+ Covid-19 IgM/IgG Rapid Test reveal the specific IgM antibody in blood several days after initial infection,  and the specific IgG antibody after 4-5 day infection. Both positive IgG and IgM result is indicative between acute and recent infection. 
     
    Positive results must be confirmed by viral nucleic acid detection by RT-PCR for confirmation of COVID-19 virus infection. This test should not be used as the sole method of diagnosing a Covid-19 infection.
     

Company Profile

  • Bioassayplus Inc.
  • [ Canada ]
  • This company is registered as a free member and is not verified or authenticated by Tradekey.com
  • BioassayPlus Inc. is the manufacturer of diagnostic products and reagents with ISO13485-2016 certification. We supply finished product and uncut sheet for diagnostic rapid tests for infectious diseases, heart disease and pregnancy / ovulation test. We also manufacture over 200 diagnostic reagents for diagnsotic industry and research institutions. 1. Diagnostic rapid tests include: A...

Basic Information

  • Company Products / Services: diagnostic rapid test and reagent
  • Year Established: 2012
  • Number of Employees: 6-10
  • Website: www.immunoassay.ca
Contact Now